Hudson Bay Capital Management LP Aim Immuno Tech Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$1.9 - $2.94 $242,763 - $375,643
-127,770 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$0.56 - $6.1 $71,551 - $779,397
127,770 New
127,770 $327,000
Q4 2019

Feb 12, 2020
SELL
$0.39 - $0.71 $154,011 - $280,379
-394,900 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$0.71 - $4.42 $280,379 - $1.75 Million
394,900 New
394,900 $301,000

Others Institutions Holding AIM

# of Institutions
36
Shares Held
9.01M
Call Options Held
0
Put Options Held
0
View Full List

About AIM ImmunoTech Inc.

AIM Quotes by TradingView
  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $10.1M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email